Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff ...

Major companies are lowering or scrapping their earnings forecasts amid uncertainty from tariffs.

Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

Scotiabank lowered the firm’s price target on Thermo Fisher (TMO) to $605 from $650 and keeps a Sector Perform rating on the shares. While it ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector had reported that ...

Thermo Fisher’s Q1 2025 earnings report revealed a performance as precise as a lab instrument. The company beat expectations ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 1.15% to $426.66 Thursday, on what proved to be an all-around great ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Businesses across multiple industries are increasing prices, cutting financial guidance and warning of growing uncertainty as ...

Thermo Fisher Scientific (NYSE:TMO) reported significant growth in its recent earnings report, with net income and earnings per share both showing year-over-year increases. The company also completed ...

Global businesses face uncertainty as U.S. President Trump's trade policies disrupt supply chains and escalate costs. Major companies, including P&G, PepsiCo, and Tesla, adjust profit forecasts and ...